Hims & Hers Health (HIMS) Free Cash Flow (2019 - 2026)
Hims & Hers Health (HIMS) reported Free Cash Flow of $59.5 million for Q1 2026, up 10.69% on a YoY basis from $53.8 million in Q1 2025, and down 18.37% sequentially from $72.9 million in Q4 2025.
Hims & Hers Health (HIMS) Free Cash Flow (2019 - 2026) Analysis & Trends
Hims & Hers Health (HIMS) has 8 years of Free Cash Flow data on file, last reported at $59.5 million in Q1 2026.
- For the quarter ending Q1 2026, Free Cash Flow rose 10.69% year-over-year to $59.5 million; the trailing twelve-month figure through Mar 2026 stood at $280.5 million (up 0.54% YoY), and the FY2025 full-year result was $274.8 million, up 9.45% from the prior year.
- Free Cash Flow fell to $59.5 million in Q1 2026, from $72.9 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $119.8 million in Q3 2025 to a low of -$19.4 million in Q1 2022.
- A 5-year average of $36.2 million and a median of $25.8 million in 2024 frame the typical range for Free Cash Flow.
- Across the five-year window, Free Cash Flow tumbled 600.47% in 2022 and soared 802.2% in 2024, its largest moves.
- Tracing HIMS's Free Cash Flow over 5 years: stood at -$6.7 million in 2022, then jumped by 271.11% to $11.5 million in 2023, then soared by 802.2% to $103.5 million in 2024, then declined by 29.53% to $72.9 million in 2025, then retreated by 18.37% to $59.5 million in 2026.
- Business Quant data shows HIMS's Free Cash Flow at $59.5 million in Q1 2026, $72.9 million in Q4 2025, and $119.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | -208.00 Mn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 291.00 Mn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | -373.37 Mn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 363.70 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | 348.40 Mn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 144.40 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | -38.00 Mn |
| 10 | Hims & Hers Health | 6.44 Bn | 5.69 Bn | 396.79 Mn | 59.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 59.51 Mn |
| Mar 31, 2026 | 59.51 Mn |
| Dec 31, 2025 | 72.91 Mn |
| Dec 31, 2025 | 72.91 Mn |
| Sep 30, 2025 | 119.84 Mn |
| Sep 30, 2025 | 119.84 Mn |
| Jun 30, 2025 | 28.25 Mn |
| Jun 30, 2025 | 28.25 Mn |
| Mar 31, 2025 | 53.76 Mn |
| Mar 31, 2025 | 53.76 Mn |
| Dec 31, 2024 | 103.46 Mn |
| Dec 31, 2024 | 103.46 Mn |
| Sep 30, 2024 | 68.18 Mn |
| Sep 30, 2024 | 68.18 Mn |
| Jun 30, 2024 | 53.59 Mn |
| Jun 30, 2024 | 53.59 Mn |
| Mar 31, 2024 | 25.79 Mn |
| Mar 31, 2024 | 25.79 Mn |
| Dec 31, 2023 | 11.47 Mn |
| Dec 31, 2023 | 11.47 Mn |